Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Understanding the causes of post-transplant lymphoproliferative disease
Read about Dr Heather Long's study into how post-transplant lymphoproliferative disease (PTLD) can become resistant to treatment, and what new treatments could work on the blood cancer.
How does leukaemia develop in babies?
Some babies develop leukaemias as a result of changes that happen before birth. Professor Katrin Ottersbach wants to understand more about these changes and why some babies see their cancer return despite treatment.
Creating a more personalised approach to treatment for DLBCL
Professor Du and his team at the University of Cambridge are investigating a unique feature in DLBCL cancer cells that may help them survive and resist treatment, aiming to improve understanding and improve treatment decisions for people with blood cancer
Monitoring the progression of aggressive blood cancers and finding new ways to stop them
Dr Andrejs Braun is studying a protein that he thinks may help to predict how aggressive certain types of blood cancer will be. They want to understand how and why this protein can influence the outcome of blood cancer.
Zeroing in on a pathway that drives myeloma
Researchers are studying a signalling pathway to identify new treatment targets for myeloma, a type of blood cancer.
Developing a risk score for graft-versus host disease in stem cell transplants
Graft-versus-host disease is a dangerous complication of stem or bone marrow transplant. Professor Paul Moss wants to understand more about the disease so we predict who might develop it.
Reapplying the brakes in out of control CLL cells
Chronic lymphocytic leukaemia responds to chemotherapy and other treatments, but these can stop working. Blood Cancer UK researchers look at how to overcome this.
CLARITY trial
tba
TIDaL trial
Dr Tobias Menne's TIDaL trial looks into how well rituximab and ibrutinib work together in treating people with post-transplant lymphoproliferative disorders (PTLD).
CALiBRe Trial
Chronic lymphocytic leukaemia (CLL) treatments can be effective but often cause serious side effects or are unsuitable for some patients. Researchers are testing a new CLL drug that could provide a safer, more effective treatment option.
MATCHPOINT trial
Discover a trial testing a new treatment combination for people with advanced CML who have limited options.
Making stem cell transplants safer for people with blood cancer
Dr Verma is researching to find ways to predict who is at risk of developing graft-versus-host disease (GvHD) following a stem cell transplant to find ways to prevent this.
Creating new ways to prevent the development of myeloid blood cancers
Professor Vassiliou wants to understand how myeloid cancers develop before people start showing any symptoms to create new ways to prevent people developing these blood cancers.
Improving the lives of children with leukaemia through tailored treatment
Professor Christine Harrison's project collects and analyses genetic information from children with leukaemia to try and understand how to treat the blood cancer.
Improving outcomes for people with MDS
Explore Dr Stephen Jenkins's research into two new treatments in people with MDS to see if they can improve symptoms and overall quality of life.
MAJIC trial
Professor Claire Harrison wants to trial a new drug in people who have MPN who are unable to receive standard chemotherapy.
Making CAR T-cell therapy more accessible for people with blood cancer
Dr David Coe is researching a new, quicker way to make CAR T-cells so more people with blood cancer can access this life-saving treatment.
The Precision Medicine in Aggressive Lymphoma consortium
Blood Cancer UK researchers find better ways to categorise and diagnose DLBCL. This will help ensure everyone with DLBCL gets the right treatment for them.
Using ‘fingerprints’ to understand the best ways to treat chronic lymphocytic leukaemia and diffuse large B-cell lymphoma
Professor Pepper is conducting research to understand the specific features that cause CLL and diffuse large B-cell lymphoma blood cancer cells to develop.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.